Stock Comparison
GSK vs LLY
GlaxoSmithKline PLC ADR and Eli Lilly and Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$102.57B
$1.04T
P/E (TTM)
16.2
39.1
Forward P/E
20.7
32.1
Price/Sales
3.1
13.0
Price/Book
4.3
30.6
EV/EBITDA
9.4
26.0
Dividend Yield
3.43%
0.53%
Profitability
Net Margin
17.78%
33.53%
Operating Margin
25.67%
43.92%
Return on Equity
33.40%
102.30%
Return on Assets
10.00%
20.40%
Growth (YoY)
Revenue Growth
5.30%
47.70%
Earnings Growth
-69.50%
26.20%
Price & Risk
Beta
0.3
0.5
52-Week High
$60.20
$1,235.65
52-Week Low
$37.85
$679.67
Analyst Target
$58.08
$1,297.31
Compare GSK and LLY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.